Full results from the positive phase III OBERON and TITANIA trials showed that tozorakimab is the first biologic to demonstrate statistically significa...
SHELTON, Conn., Sept. 8, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotech...
BIOCENTURY | PRODUCT DEVELOPMENTNOVARTIS' PHASE III MISSES, PHARMA DEALS ANALYSIS, MFN CARVE-OUTS - A BIOCENTURY PODCASTPlus: A tribute to Peter Barton...
Bristol Myers Squibb (BMY) has announced encouraging topline results from its registrational Phase 2 QUINTESSENTIAL trial of arlocabtagene autoleucel....
Gilead Sciences Inc, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of ...
Basel, 10 September 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Rev...
Investors allege Replimune Group, Inc. told the market its RP1 resubmission was a complete response to the FDA's prior deficiency letter, while the age...
MSD Korea has launched Enflonsia Prefilled Syringe (clesrovimab-cfor), a long-acting preventive antibody designed to protect newborns and infants enter...
Frequently Asked Questions about Pharma-GPS
Who are Pharma-GPS's top competitors?
Pharma-GPS's top 3 competitors are Rhenovia Development, Virtual Pharma Rep, The Readysun Pharma.
Who is similar to Pharma-GPS?
Rhenovia Development is the most similar to Pharma-GPS. Virtual Pharma Rep and The Readysun Pharma are also similar to Pharma-GPS.
Are Pharma-GPS and Rhenovia Development competitors?
Yes, Rhenovia Development is one of Pharma-GPS’s top competitors.